Trial Profile
Lactobacillus-reuteri to prevent colic in Canadian infants
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Nov 2015
Price :
$35
*
At a glance
- Drugs Limosilactobacillus reuteri (Primary)
- Indications Colic
- Focus Adverse reactions; Therapeutic Use
- 30 Nov 2015 New trial record